| Sertindole |
9800286 |
SERDOLECT, Film‐coated tablet, 4, mg, Pack: 30 |
Lundbeck Export A/S, Дания |
H. Lundbeck A/S, Дания |
35.91 |
7.18 |
43.09 |
4% |
1.44 |
37.35 |
7.47 |
44.82 |
16% |
5.75 |
43.1 |
8.62 |
51.72 |
|
НСР-5580/05.02.2015. |
19.02.2015 |
Неактивен |
3572 |
| Sertindole |
9800286 |
SERDOLECT, Film‐coated tablet, 4, mg, Pack: 30 |
Lundbeck Export A/S, Дания |
H. Lundbeck A/S, Дания |
36.55 |
7.31 |
43.86 |
4% |
1.46 |
38.01 |
7.6 |
45.61 |
16% |
5.85 |
43.86 |
8.77 |
52.63 |
|
НСР-1728/21.11.2013 |
09.12.2013 |
Неактивен |
3572 |
| Sertindole |
1405/15.01.2008 г. |
SERDOLECT, Film‐coated tablet, 4, mg, Pack: 30 |
Lundbeck Export A/S, Дания |
H. Lundbeck A/S, Дания |
39.31 |
7.86 |
47.17 |
4% |
1.57 |
40.88 |
8.18 |
49.06 |
16% |
6.29 |
47.17 |
9.43 |
56.6 |
|
КЦРР-2548/14.03.2013 |
03.04.2013 |
Неактивен |
3572 |
| Sertindole |
1405/15.01.2008 г. |
SERDOLECT, Film‐coated tablet, 4, mg, Pack: 30 |
Lundbeck Export A/S, Дания |
H. Lundbeck A/S, Дания |
42.83 |
8.57 |
51.4 |
4% |
1.71 |
44.54 |
8.91 |
53.45 |
16% |
6.85 |
51.39 |
10.28 |
61.67 |
|
КЦ-148/04.07.2008 |
25.07.2008 |
Неактивен |
3572 |
| Sertindole |
9800286 |
SERDOLECT, Film‐coated tablet, 12, mg, Pack: 28 |
Lundbeck Export A/S, Дания |
H. Lundbeck A/S, Дания |
107.82 |
21.56 |
129.38 |
4% |
4.31 |
112.13 |
22.43 |
134.56 |
16% |
17.25 |
129.38 |
25.88 |
155.26 |
|
НСР-9119/27.04.2016 |
02.06.2016 |
Активен |
3487 |
| Sertindole |
9800286 |
SERDOLECT, Film‐coated tablet, 12, mg, Pack: 28 |
Lundbeck Export A/S, Дания |
H. Lundbeck A/S, Дания |
108.35 |
21.67 |
130.02 |
4% |
4.33 |
112.68 |
22.54 |
135.22 |
16% |
17.34 |
130.02 |
26 |
156.02 |
|
НСР-7077/09.09.2015 |
25.09.2015 |
Неактивен |
3487 |
| Sertindole |
9800284 |
SERDOLECT, Film‐coated tablet, 16, mg, Pack: 28 |
Lundbeck Export A/S, Дания |
H. Lundbeck A/S, Дания |
142.89 |
28.58 |
171.47 |
4% |
5.72 |
148.61 |
29.72 |
178.33 |
16% |
22.86 |
171.47 |
34.29 |
205.76 |
|
НСР-7591/26.11.2015. |
12.12.2015 |
Активен |
3788 |
| Sertindole |
9800284 |
SERDOLECT, Film‐coated tablet, 16, mg, Pack: 28 |
Lundbeck Export A/S, Дания |
H. Lundbeck A/S, Дания |
145.01 |
29 |
174.01 |
4% |
5.8 |
150.81 |
30.16 |
180.97 |
16% |
23.2 |
174.01 |
34.8 |
208.81 |
|
НСР-5981/01.04.2015. |
16.04.2015 |
Неактивен |
3788 |
| Sertindole |
9800286 |
SERDOLECT, Film‐coated tablet, 12, mg, Pack: 28 |
Lundbeck Export A/S, Дания |
H. Lundbeck A/S, Дания |
109.45 |
21.89 |
131.34 |
4% |
4.38 |
113.83 |
22.77 |
136.6 |
16% |
17.51 |
131.34 |
26.27 |
157.61 |
|
НСР-5395/07.01.2015. |
21.01.2015 |
Неактивен |
3487 |
| Sertindole |
9800284 |
SERDOLECT, Film‐coated tablet, 16, mg, Pack: 28 |
Lundbeck Export A/S, Дания |
H. Lundbeck A/S, Дания |
148.12 |
29.62 |
177.74 |
4% |
5.92 |
154.04 |
30.81 |
184.85 |
16% |
23.7 |
177.74 |
35.55 |
213.29 |
|
НСР-4336/05.08.2014 |
20.08.2014 |
Неактивен |
3788 |
| Sertindole |
9800286 |
SERDOLECT, Film‐coated tablet, 12, mg, Pack: 28 |
Lundbeck Export A/S, Дания |
H. Lundbeck A/S, Дания |
111.93 |
22.39 |
134.32 |
4% |
4.48 |
116.41 |
23.28 |
139.69 |
16% |
17.91 |
134.32 |
26.86 |
161.18 |
|
НСР-3331/24.04.2014 |
08.05.2014 |
Неактивен |
3487 |
| Sertindole |
9800284 |
SERDOLECT, Film‐coated tablet, 16, mg, Pack: 28 |
Lundbeck Export A/S, Дания |
H. Lundbeck A/S, Дания |
155.78 |
31.16 |
186.94 |
4% |
6.23 |
162.01 |
32.4 |
194.41 |
16% |
24.92 |
186.93 |
37.39 |
224.32 |
|
НСР-1729/21.11.2013 |
09.12.2013 |
Неактивен |
3788 |
| Sertindole |
9800286 |
SERDOLECT, Film‐coated tablet, 16, mg, Pack: 28 |
Lundbeck Export A/S, Дания |
H. Lundbeck A/S, Дания |
157.6 |
31.52 |
189.12 |
4% |
6.3 |
163.9 |
32.78 |
196.68 |
16% |
25 |
188.9 |
37.78 |
226.68 |
|
КЦРР-2544/14.03.2013 |
03.04.2013 |
Неактивен |
3788 |
| Sertindole |
9800286 |
SERDOLECT, Film‐coated tablet, 12, mg, Pack: 28 |
Lundbeck Export A/S, Дания |
H. Lundbeck A/S, Дания |
118.21 |
23.64 |
141.85 |
4% |
4.73 |
122.94 |
24.59 |
147.53 |
16% |
18.91 |
141.85 |
28.37 |
170.22 |
|
КЦРР-2545/14.03.2013 |
03.04.2013 |
Неактивен |
3487 |
| Sertindole |
1403/15.01.2008 г. |
SERDOLECT, Film‐coated tablet, 16, mg, Pack: 28 |
Lundbeck Export A/S, Дания |
H. Lundbeck A/S, Дания |
173.93 |
34.79 |
208.72 |
4% |
6.96 |
180.89 |
36.18 |
217.07 |
16% |
25 |
205.89 |
41.18 |
247.07 |
|
КЦ-148/04.07.2008 |
25.07.2008 |
Неактивен |
3788 |
| Sertindole |
1404/15.01.2008 г. |
SERDOLECT, Film‐coated tablet, 12, mg, Pack: 28 |
Lundbeck Export A/S, Дания |
H. Lundbeck A/S, Дания |
127.93 |
25.59 |
153.52 |
4% |
5.12 |
133.05 |
26.61 |
159.66 |
16% |
20.47 |
153.52 |
30.7 |
184.22 |
|
КЦ-148/04.07.2008 |
25.07.2008 |
Неактивен |
3487 |
| Salmeterol, Fluticasone |
20000234 |
SERETIDE DISCUS, Inhalation powder, 50 mcg/100 mcg/dose - 60 doses, UD, Pack: 1 |
ГлаксоСмитКлайн ЕООД, България |
Glaxo Wellcome Operations (Glaxo Operations UK Ltd.), UK |
33.43 |
6.69 |
40.12 |
4% |
1.34 |
34.77 |
6.95 |
41.72 |
16% |
5.35 |
40.12 |
8.02 |
48.14 |
Отхвърля като неоснователна жалбата Комисия по прозрачност с решение КП-189/30.04.2015 |
НСР-6182/08.05.2015 |
02.06.2015 |
Активен |
3879 |
| Salmeterol, Fluticasone |
20000234 |
SERETIDE DISCUS, Inhalation powder, 50 mcg/100 mcg/dose - 60 doses, UD, Pack: 1 |
ГлаксоСмитКлайн ЕООД, България |
Glaxo Wellcome Operations (Glaxo Operations UK Ltd.), UK |
33.43 |
6.69 |
40.12 |
4% |
1.34 |
34.77 |
6.95 |
41.72 |
16% |
5.35 |
40.12 |
8.02 |
48.14 |
Отхвърля като неоснователна жалбата Комисия по прозрачност с решение КП-189/30.04.2015 |
НСР-6182/08.05.2015 |
02.06.2015 |
Неактивен |
3879 |
| Salmeterol, Fluticasone |
20000232 |
SERETIDE DISCUS, Inhalation powder, 50 mcg/250 mcg/dose - 60 doses, UD, Pack: 1 |
ГлаксоСмитКлайн ЕООД, България |
Glaxo Wellcome Production, France; Glaxo Wellcome Operations (Glaxo Operations UK, Ltd.) - UK |
44.83 |
8.97 |
53.8 |
4% |
1.79 |
46.62 |
9.32 |
55.94 |
16% |
7.17 |
53.79 |
10.76 |
64.55 |
|
НСР-6675/09.07.2015 |
25.07.2015 |
Активен |
3331 |
| Salmeterol, Fluticasone |
20000232 |
SERETIDE DISCUS, Inhalation powder, 50 mcg/250 mcg/dose - 60 doses, UD, Pack: 1 |
ГлаксоСмитКлайн ЕООД, България |
Glaxo Wellcome Production, France; Glaxo Wellcome Operations (Glaxo Operations UK, Ltd.) - UK |
44.83 |
8.97 |
53.8 |
4% |
1.79 |
46.62 |
9.32 |
55.94 |
16% |
7.17 |
53.79 |
10.76 |
64.55 |
|
НСР-6675/09.07.2015 |
25.07.2015 |
Неактивен |
3331 |
| Salmeterol, Fluticasone |
20000232 |
SERETIDE DISCUS, Inhalation powder, 50 mcg/250 mcg/dose - 60 doses, UD, Pack: 1 |
ГлаксоСмитКлайн ЕООД, България |
Glaxo Wellcome Production, France; Glaxo Wellcome Operations (Glaxo Operations UK, Ltd.) - UK |
49.7 |
9.94 |
59.64 |
4% |
1.99 |
51.69 |
10.34 |
62.03 |
16% |
7.95 |
59.64 |
11.93 |
71.57 |
промяна на обстоятелства Решение НСР-5179/27.11.2014; Решение КП-7/15.01.2015 и НСР-844/07.08.2013 |
НСР-4904/22.10.2014 |
06.11.2014 |
Неактивен |
3331 |
| Salmeterol, Fluticasone |
20000233 |
SERETIDE DISCUS, Inhalation powder, 50 mcg/500 mcg/dose - 60 doses, UD, Pack: 1 |
ГлаксоСмитКлайн ЕООД, България |
Glaxo Wellcome Operations (Glaxo Operations UK Ltd.), UK |
68.24 |
13.65 |
81.89 |
4% |
2.73 |
70.97 |
14.19 |
85.16 |
16% |
10.92 |
81.89 |
16.38 |
98.27 |
Отхвърлена жалба от Комисия по прозрачност КП-100/03.11.2014 на Решение НСР-2644/03.02.2014 |
НСР-4601/15.09.2014 |
30.09.2014 |
Активен |
3205 |
| Salmeterol, Fluticasone |
20000234 |
SERETIDE DISCUS, Inhalation powder, 50 mcg/100 mcg/dose - 60 doses, UD, Pack: 1 |
ГлаксоСмитКлайн ЕООД, България |
Glaxo Wellcome Operations (Glaxo Operations UK Ltd.), UK |
36.97 |
7.39 |
44.36 |
4% |
1.48 |
38.45 |
7.69 |
46.14 |
16% |
5.92 |
44.37 |
8.87 |
53.24 |
|
НСР-2703/06.02.2014 |
03.03.2014 |
Неактивен |
3879 |
| Salmeterol, Fluticasone |
20000232 |
SERETIDE DISCUS, Inhalation powder, 50 mcg/250 mcg/dose - 60 doses, UD, Pack: 1 |
ГлаксоСмитКлайн ЕООД, България |
Glaxo Wellcome Production, France; Glaxo Wellcome Operations (Glaxo Operations UK, Ltd.) - UK |
50.71 |
10.14 |
60.85 |
4% |
2.03 |
52.74 |
10.55 |
63.29 |
16% |
8.11 |
60.85 |
12.17 |
73.02 |
|
НСР-2643/03.02.2014 |
20.02.2014 |
Неактивен |
3331 |
| Salmeterol, Fluticasone |
6755/26.01.2010 |
SERETIDE DISCUS, Inhalation powder, 50 mcg/500 mcg/dose - 60 doses, UD, Pack: 1 |
ГлаксоСмитКлайн ЕООД, България |
Glaxo Wellcome Operations (Glaxo Operations UK Ltd.), UK |
76.36 |
15.27 |
91.63 |
4% |
3.05 |
79.41 |
15.88 |
95.29 |
16% |
12.22 |
91.63 |
18.33 |
109.96 |
КЦ-1574/12.05.2010 за промяна на обстоятелства |
КЦ-328/28.11.2008 |
22.12.2008 |
Неактивен |
3205 |